InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Starr Kevin P, 董事. Director active across 1 company, notably Sage Therapeutics, Inc.. Aggregated, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €834k. History available since 16 June 2021. The latest transaction was filed on 16 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Starr Kevin P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
17,842 股@ US$56.0466100.0% 占其流量Common StockSEC:0001562180-21-004343:0
标准退出：2021年9月14日 (T+90)
1 条申报中的 1 条
About Starr Kevin P
Kevin P. Starr is a Board Member at Sage Therapeutics, Inc. He plays a key role in the strategic direction of the company, ensuring it adheres to best practices in governance. His experience in the healthcare sector is an asset for innovation initiatives.
